Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Proc Natl Acad Sci U S A
1996 Jun 11;9312:5715-9. doi: 10.1073/pnas.93.12.5715.
Show Gene links
Show Anatomy links
Mutation of a conserved serine in TM4 of opioid receptors confers full agonistic properties to classical antagonists.
Claude PA
,
Wotta DR
,
Zhang XH
,
Prather PL
,
McGinn TM
,
Erickson LJ
,
Loh HH
,
Law PY
.
???displayArticle.abstract???
The involvement of a conserved serine (Ser196 at the mu-, Ser177 at the delta-, and Ser187 at the kappa-opioid receptor) in receptor activation is demonstrated by site-directed mutagenesis. It was initially observed during our functional screening of a mu/delta-opioid chimeric receptor, mu delta2, that classical opioid antagonists such as naloxone, naltrexone, naltriben, and H-Tyr-Tic[psi,CH2NH]Phe-Phe-OH (TIPPpsi; Tic = 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid) could inhibit forskolin-stimulated adenylyl cyclase activity in CHO cells stably expressing the chimeric receptor. Antagonists also activated the G protein-coupled inward rectifying potassium channel (GIRK1) in Xenopus oocytes coexpressing the mu delta2 opioid receptor and the GIRK1 channel. By sequence analysis and back mutation, it was determined that the observed antagonist activity was due to the mutation of a conserved serine to leucine in the fourth transmembrane domain (S196L). The importance of this serine was further demonstrated by analogous mutations created in the mu-opioid receptor (MORS196L) and delta-opioid receptor (DORS177L), in which classical opioid antagonists could inhibit forskolin-stimulated adenylyl cyclase activity in CHO cells stably expressing either MORS196L or DORS177L. Again, antagonists could activate the GIRK1 channel coexpressed with either MORS196L or DORS177L in Xenopus oocytes. These data taken together suggest a crucial role for this serine residue in opioid receptor activation.
Birnbaum,
Functional expression of adrenergic and opioid receptors in Xenopus oocytes: interaction between alpha 2- and beta 2-adrenergic receptors.
1995, Pubmed,
Xenbase
Birnbaum,
Functional expression of adrenergic and opioid receptors in Xenopus oocytes: interaction between alpha 2- and beta 2-adrenergic receptors.
1995,
Pubmed
,
Xenbase
Chakrabarti,
Expression of the mu-opioid receptor in CHO cells: ability of mu-opioid ligands to promote alpha-azidoanilido[32P]GTP labeling of multiple G protein alpha subunits.
1995,
Pubmed
Chakrabarti,
Neuroblastoma Neuro2A cells stably expressing a cloned mu-opioid receptor: a specific cellular model to study acute and chronic effects of morphine.
1995,
Pubmed
Chen,
Calcium phosphate-mediated gene transfer: a highly efficient transfection system for stably transforming cells with plasmid DNA.
1988,
Pubmed
Chen,
Molecular cloning and functional expression of a mu-opioid receptor from rat brain.
1993,
Pubmed
Dascal,
Atrial G protein-activated K+ channel: expression cloning and molecular properties.
1993,
Pubmed
,
Xenbase
Eason,
Simultaneous coupling of alpha 2-adrenergic receptors to two G-proteins with opposing effects. Subtype-selective coupling of alpha 2C10, alpha 2C4, and alpha 2C2 adrenergic receptors to Gi and Gs.
1992,
Pubmed
Evans,
Cloning of a delta opioid receptor by functional expression.
1992,
Pubmed
Fukuda,
Primary structures and expression from cDNAs of rat opioid receptor delta- and mu-subtypes.
1993,
Pubmed
Fukuda,
Location of regions of the opioid receptor involved in selective agonist binding.
1995,
Pubmed
Gulya,
Cyclic somatostatin octapeptide analogues with high affinity and selectivity toward mu opioid receptors.
1986,
Pubmed
Henry,
Kappa-opioid receptors couple to inwardly rectifying potassium channels when coexpressed by Xenopus oocytes.
1995,
Pubmed
,
Xenbase
Hescheler,
The GTP-binding protein, Go, regulates neuronal calcium channels.
,
Pubmed
Jin,
Dual excitatory and inhibitory effects of opioids on intracellular calcium in neuroblastoma x glioma hybrid NG108-15 cells.
1992,
Pubmed
Kieffer,
The delta-opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization.
1992,
Pubmed
Kong,
A single residue, aspartic acid 95, in the delta opioid receptor specifies selective high affinity agonist binding.
1993,
Pubmed
LOWRY,
Protein measurement with the Folin phenol reagent.
1951,
Pubmed
Law,
Opiate receptor down-regulation and desensitization in neuroblastoma X glioma NG108-15 hybrid cells are two separate cellular adaptation processes.
1983,
Pubmed
Law,
Analysis of delta-opioid receptor activities stably expressed in CHO cell lines: function of receptor density?
1994,
Pubmed
Meng,
A chimeric study of the molecular basis of affinity and selectivity of the kappa and the delta opioid receptors. Potential role of extracellular domains.
1995,
Pubmed
Meng,
Cloning and pharmacological characterization of a rat kappa opioid receptor.
1993,
Pubmed
Minami,
DAMGO, a mu-opioid receptor selective ligand, distinguishes between mu-and kappa-opioid receptors at a different region from that for the distinction between mu- and delta-opioid receptors.
1995,
Pubmed
Munson,
Ligand: a versatile computerized approach for characterization of ligand-binding systems.
1980,
Pubmed
North,
Mu and delta receptors belong to a family of receptors that are coupled to potassium channels.
1987,
Pubmed
Onogi,
DAMGO, a mu-opioid receptor selective agonist, distinguishes between mu- and delta-opioid receptors around their first extracellular loops.
1995,
Pubmed
Piros,
Ca2+ channel and adenylyl cyclase modulation by cloned mu-opioid receptors in GH3 cells.
1995,
Pubmed
Sharma,
Morphine receptors as regulators of adenylate cyclase activity.
1975,
Pubmed
Surratt,
-mu opiate receptor. Charged transmembrane domain amino acids are critical for agonist recognition and intrinsic activity.
1994,
Pubmed
White,
Improved two-step method for the assay of adenylate and guanylate cyclase.
1978,
Pubmed
Wimpey,
Opioids activate both an inward rectifier and a novel voltage-gated potassium conductance in the hippocampal formation.
1991,
Pubmed
Xue,
The third extracellular loop of the mu opioid receptor is important for agonist selectivity.
1995,
Pubmed
Yasuda,
Cloning and functional comparison of kappa and delta opioid receptors from mouse brain.
1993,
Pubmed
Yu,
Efficacy and tolerance of narcotic analgesics at the mu opioid receptor in differentiated human neuroblastoma cells.
1988,
Pubmed
